Intravascular Lithotripsy Market size is predicted to reach USD 155 billion by the end of 2036, expanding around 12% CAGR during the forecast period i.e., 2024-2036. In the year 2023, the industry size of intravascular lithotripsy was over USD 2 billion. The growth of this market can be attributed on the account of growing prevalence of cardiovascular diseases all across the globe. Cardiovascular diseases, such as coronary heart disease and peripheral artery disease, are increasing worldwide due to unhealthy lifestyles, changes in dietary habits and aging populations. This has increased the need for effective treatments and minimally invasive procedures such as angioplasty or stenting, thus raising the demand for intravascular lithotripsy. According to WHO, cardiovascular disease is the leading cause of death worldwide, with about 17.9 million deaths each year.
Furthermore, the escalating existence of complexities associated with kidney stones is the main factor driving the market expansion of intravascular lithotripsy. Besides, the growing adoption of intravascular lithotripsy in order to treat patients with coronary artery disease and constant ongoing research and development in intravascular lithotripsy further is positively influencing the market growth in the projected time frame.
Growth Drivers
Challenges
|
Base Year |
2023 |
|
Forecast Year |
2024 - 2036 |
|
CAGR |
~12% |
|
Base Year Market Size |
~USD 2 billion |
|
Forecast Year Market Size |
~USD 155 billion |
|
Regional Scope |
|
Application Type (Coronary Artery Disease, Kidney Disorder, Facilitated Vascular Access, Peripheral Arterial Disease)
Intravascular lithotripsy market from the coronary artery disease segment is set to hold the largest revenue share of 40 % by the end of 2036. Coronary heart disease is one of the most common types of cardiovascular disease and is the third leading cause of death worldwide. The high incidence of coronary heart disease has led to an increased demand for effective treatments such as intravascular lithotripsy. Intravascular lithotripsy is very effective in treating calcified plaque, a common complication of coronary artery disease. The ability of intravascular lithotripsy to safely and effectively treat calcified plaque makes it the preferred treatment option for patients with coronary artery disease.
End User (Hospitals, Specialty Clinics)
Based on end user, the specialty clinics segment in the intravascular lithotripsy market is predicted grow substantially during the time period between 2024 – 2036. Specialty clinics focus on specific medical conditions or procedures, such as cardiovascular disease. Highly qualified medical professionals often use them. This focus allows them to provide exceptional care to patients requiring intravascular lithotripsy. Specialty clinics are often more accessible, less complicated, and more convenient for patients than hospitals. This convenience makes it easier for patients to find treatment methods, thereby contributing to the revenue growth of the specialized clinic segment in the market. Specialty clinics often have shorter wait times for appointments and procedures than hospitals, which can benefit patients who need intravascular lithotripsy. Reducing wait times can increase patient satisfaction and encourage more patients to seek care at specialty clinics. Specialty clinics typically have lower overhead costs than hospitals, which results in lower procedure costs for patients.
Our in-depth analysis of the global market includes the following segments:
|
Application Type |
|
|
End User |
|
North America Market Forecasts
The intravascular lithotripsy market in North America market is estimated to account for the highest CAGR of 35% by the end of 2036. North America has a favorable reimbursement policy for intravascular lithotripsy procedures, which encourages healthcare providers to offer intravenous lithotripsy as a viable treatment option. North America has a highly developed healthcare system and the region is at the forefront of rapid adoption of technological developments. Additionally, an increasing number of people suffering from kidney and cardiac disorders is also driving the growth market in this region during the estimated time period. In the United States one person in every 33 seconds loses their life to cardiac disorder.
Asia Pacific Market Statistics
The intravascular lithotripsy market in the Asia Pacific region is estimated to witness a significant market share during the time period between 2024 – 2036. The growth of this market can be primarily driven by the account of increasing awareness about intravascular lithotripsy among the people of this region along with changes in the lifestyle that results in a higher number of people suffering from chronic illness. Furthermore, rising healthcare expenditure in the region is also driving the growth of the market in the APAC region during the projected timeframe.
Author Credits: Radhika Gupta, Shivam Bhutani
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?